Multimodality endoscopic eradication for neoplastic Barrett oesophagus: Results of an European multicentre study (EURO-II)

K. Nadine Phoa, Roos E. Pouw, Raf Bisschops, Oliver Pech, Krish Ragunath, Bas L A M Weusten, Brigitte Schumacher, Bjorn Rembacken, Alexander Meining, Helmut Messmann, Erik J. Schoon, Liebwin Gossner, Jayan Mannath, C. A. Seldenrijk, Mike Visser, Toni Lerut, Stefan Seewald, Fiebo J. ten Kate, Christian Ell, Horst NeuhausJacques J G H M Bergman*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

Objective Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely and effectively eradicates Barrett's oesophagus (BO) containing high-grade dysplasia (HGD) and/or early cancer (EC) in smaller studies with limited follow-up. Herein, we report long-term outcomes of combined ER and RFA for BO (HGD and/or EC) from a single-arm multicentre interventional study. Design In 13 European centres, patients with BO≤12 cm with HGD and/or EC on 2 separate endoscopies were eligible for inclusion. Visible lesions (

Original languageEnglish
Pages (from-to)555 – 562
JournalGut
Volume65
Issue number4
DOIs
Publication statusPublished - 2 Mar 2015

Fingerprint

Dive into the research topics of 'Multimodality endoscopic eradication for neoplastic Barrett oesophagus: Results of an European multicentre study (EURO-II)'. Together they form a unique fingerprint.

Cite this